Part II of the report identifies several disruptive technologies that may overcome the challenges of mainstream treatments.
Browsing: pre-cancer
In response to some recent successes by several companies operating in the cervical cancer space, we are issuing a two-part special report exploring pre-cervical cancer and CIN.